Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients
Abstract Background Recurrence of cancer after curative surgery is a major problem after most cancer treatments.Increased sympathetic activity during the perioperative period 6 Piece Outdoor Modular Seating could promote cancer cell invasion to blood vessels and angiogenesis, resulting in cancer metastasis.Recent studies showed that use of beta blo